相似文献
1
Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated Treatments.
Cancers (Basel). 2020 Sep 24;12(10):2737. doi: 10.3390/cancers12102737.
2
Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver.
Semin Oncol. 2010 Apr;37(2):149-59. doi: 10.1053/j.seminoncol.2010.03.005.
3
Current status of transarterial radioembolization.
World J Radiol. 2016 May 28;8(5):449-59. doi: 10.4329/wjr.v8.i5.449.
4
[Role of loco-regional treatments for patients with breast cancer liver metastases].
Recenti Prog Med. 2009 Sep;100(9):424-33.
5
Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma.
Clin Pharmacokinet. 2019 Aug;58(8):983-1014. doi: 10.1007/s40262-019-00740-w.
6
[Hepatic arterial infusion chemotherapy and loco-regional treatment and irradiation of pancreas tumor in non-resectable pancreas cancer with liver metastases].
Gan To Kagaku Ryoho. 1991 Aug;18(11):1776-9.
7
Regional Transcatheter Therapy of Hepatic Neoplasms.
Cancer Control. 1996 Oct;3(5):407-413. doi: 10.1177/107327489600300502.
8
Interventional radiology approaches for intra-hepatic cholangiocarcinoma.
Chin Clin Oncol. 2020 Feb;9(1):8. doi: 10.21037/cco.2019.12.15. Epub 2020 Jan 18.
9
[Loco-regional therapy for liver malignancy in Iceland].
Laeknabladid. 2012 Jun;98(6):334-40. doi: 10.17992/lbl.2012.06.437.
10
[A new regional arterial infusion chemotherapy for patients with advanced pancreatic cancer].
Gan To Kagaku Ryoho. 2002 Mar;29(3):383-9.
引用本文的文献
1
Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy.
BMC Cancer. 2024 Aug 2;24(1):941. doi: 10.1186/s12885-024-12695-8.
2
Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.
Int J Mol Sci. 2024 Jul 15;25(14):7737. doi: 10.3390/ijms25147737.
3
Clinical Updates for Gastrointestinal Malignancies.
J Pers Med. 2023 Sep 21;13(9):1424. doi: 10.3390/jpm13091424.
4
Immunotherapy and Pancreatic Cancer: A Lost Challenge?
Life (Basel). 2023 Jun 30;13(7):1482. doi: 10.3390/life13071482.
5
Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma.
Cancers (Basel). 2023 Jan 20;15(3):654. doi: 10.3390/cancers15030654.
6
Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities.
Cancers (Basel). 2022 Aug 20;14(16):4028. doi: 10.3390/cancers14164028.
7
Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature.
Front Oncol. 2022 Apr 19;12:785888. doi: 10.3389/fonc.2022.785888. eCollection 2022.
8
A Patient With Stage III Locally Advanced Pancreatic Adenocarcinoma Treated With Intra-Arterial Infusion FOLFIRINOX: Impressive Tumoral Response and Death due to Infection: A Unique Case Report.
Front Oncol. 2022 Mar 31;12:877334. doi: 10.3389/fonc.2022.877334. eCollection 2022.
9
Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review.
Cancers (Basel). 2022 Jan 17;14(2):450. doi: 10.3390/cancers14020450.
10
Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art.
Cancers (Basel). 2021 Jun 21;13(12):3091. doi: 10.3390/cancers13123091.
本文引用的文献
1
Local treatment with deep percutaneous electrochemotherapy of different tumor lesions: pain relief and objective response results from an observational study.
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7764-7775. doi: 10.26355/eurrev_202007_22279.
2
Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular Carcinoma.
Surg Oncol Clin N Am. 2019 Oct;28(4):717-729. doi: 10.1016/j.soc.2019.06.008. Epub 2019 Aug 7.
3
Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review.
JAMA Surg. 2019 Aug 1;154(8):768-776. doi: 10.1001/jamasurg.2019.1694.
4
Epidemiology and burden of pancreatic cancer.
Presse Med. 2019 Mar;48(3 Pt 2):e113-e123. doi: 10.1016/j.lpm.2019.02.030. Epub 2019 Mar 14.
5
Cholangiocarcinoma: Epidemiology and risk factors.
Liver Int. 2019 May;39 Suppl 1:19-31. doi: 10.1111/liv.14095. Epub 2019 Mar 24.
6
Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application.
Cancers (Basel). 2019 Jan 24;11(2):141. doi: 10.3390/cancers11020141.
7
Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases.
Hepat Oncol. 2015 Jul;2(3):275-290. doi: 10.2217/hep.15.9. Epub 2015 Jul 27.
8
NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021.
9
A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience.
Onco Targets Ther. 2016 Dec 12;9:7527-7535. doi: 10.2147/OTT.S112670. eCollection 2016.
10
Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients.
World J Gastroenterol. 2015 May 21;21(19):6018-25. doi: 10.3748/wjg.v21.i19.6018.
Zotero 插件